R. A. Maxwell, H. L. White (1978). Tricyclic and monoamine oxidase inhitor antidepressants:
structure–activity relations. In: L. L. Iversen, S. D. Iversen, S. H. Snyder (Eds.). Handbook
of Psychopharmacology, vol. 14. New York: Plenum Press, pp. 83–155.
M. Naoi, W. Maruyama, G. M. Nagy (2004). Dopamine-derived salsolinol derivatives as endoge-
nous monoamine oxidase inhibitors: occurrence, metabolism and function in human brains.
Neurotoxicology 25: 193–204.
R. R. Ramsay, M. B. Gravestock (2003). Monoamine oxidases: to inhibit or not to inhibit. Mini-
Rev. Med. Chem. 3: 129–136.
M. Strolin Benedetti, P. Dostert (1985). Stereochemical aspects of MAO interactions: reversible
and selective inhibitors of monoamine oxidase. Trends Pharmacol. Sci. 6: 246–251.
M. Tuncel, V. C. S. Ram (2003). Hypertensive emergencies: etiology and management. Am.
J. Cardiovasc. Drugs 3: 21–31.
Enzyme Targets: Proteases and Kinases
S. Chakravarty, S. Dugar (2002). Inhibitors of p38αMAL kinase. Annu. Rep. Med. Chem. 37: 177.
Y. Dai, S. Grant (2003). Cyclin-dependent kinase inhibitors. Curr. Opin. Pharmacol. 3: 362–370.
S. D. Kimball, K. R. Webster (2001). Cell cycle kinases and checkpoint regulation in cancer.
Annu. Rep. Med. Chem. 36: 139.
M. E. Noble, J. Endicott, L. Johnson (2004). Protein kinase inhibitors. Science 303: 1800–1803.
J. T. Randolph, D. A. DeGoey (2004). Peptidomimetic inhibitors of HIV protease. Curr. Top.
Med. Chem. 4: 1079–1095.
P. A. Renhowe (2001). Growth factor receptor kinases in cancer. Annu. Rep. Med. Chem. 36: 109.
C. T. Supuran, A. Casini, A. Scozzafava (2003). Protease inhibitors of the sulfonamide type:
anticancer, antiinflammatory, and antiviral agents. Med. Res. Rev. 23: 535–558.
Enzyme Cofactors: Vitamins
H. F. DeLuca, H. K. Schnoes (1984). Vitamin D: metabolism and mechanism of action. Annu.
Rep. Med. Chem. 19: 179–190.
D. Hornig (1982). Requirement of vitamin C in man. Trends Pharmacol. Sci. 3: 294–296.
L. J. Machlin (Ed.) (1984). Handbook of Vitamins: Nutritional, Biochemical and Clinical
Aspects.New York: Marcel Dekker.
D. P. McDonnell, D. L. Mangelsdorf, J. W. Pike, M. R. Haussler, B. W. O’Malley (1987).
Molecular cloning of complementary DNA encoding the avian receptor for vitamin D.
Science 235: 1214–1217.
L. Ovesen (1984). Vitamin therapy in the absence of obvious deficiency. What is the evidence?
Drugs 27: 148–170.
S. Vertuani, A. Angusti, S. Manfredini (2004). The antioxidants and pro-antioxidants network: an
overview. Curr. Pharm. Des. 10: 1677–1694.
Proteins as Drug Design Targets: Non-Enzymes
F. E. Cohen, J. W. Kelly (2003). Therapeutic approaches to protein-misfolding diseases. Nature
426 : 905–908.
C. M. Dobson (2003). Protein folding and misfolding. Nature 426: 884–890.
G. M. Hirschfield, P. N. Hawkins (2003). Amyloidosis: new strategies for treatment. Int.
J. Biochem. Cell Biol. 35: 1608–1613.
540 MEDICINAL CHEMISTRY